[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369153-105":59,"doc-detail-369153-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","analysing-dna-methylation-and-transcriptomic-signatures-to-predict-prostate-cancer-recurrence-risk","Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk","","Prostate cancer remains a major global health challenge, with recurrence after localized disease posing a high risk driven by residual biology. Traditional tests such as PSA screening, DRE, and biopsy suffer from limited specificity, increasing overdiagnosis and overtreatment. This study applies machine learning to identify DNA methylation and RNA expression biomarkers predictive of prostate cancer recurrence using TCGA data, integrating differential genes, correlation signatures, and an SVM model validated experimentally.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/analysing-dna-methylation-and-transcriptomic-signatures-to-predict-prostate-cancer-recurrence-risk/369153/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/analysing-dna-methylation-and-transcriptomic-signatures-to-predict-prostate-cancer-recurrence-risk/369153.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is predicting prostate cancer recurrence important?","Question",{"text":113,"@type":114},"Recurrence significantly increases risk due to inherent biological factors and residual disease. Early prediction supports timely intervention and can improve outcomes and survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What biomarkers and data were used to build the recurrence prediction model?",{"text":118,"@type":114},"The study uses DNA methylation and RNA expression biomarkers derived from TCGA datasets. It identifies differentially methylated genes and differentially expressed genes between recurrence and non-recurrence groups.",{"name":120,"@type":111,"acceptedAnswer":121},"How was the predictive model constructed and evaluated?",{"text":122,"@type":114},"A support vector machine (SVM) model was developed using ten genes showing significant methylation-expression correlations. The model achieved an AUC of 0.773 and multivariate regression supported the SVM score as an independent predictor.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369153,1790804941,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Research  \nAnalysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk  \nFahad M. Aldakheel1 · Hadeel Alnajran1 · Shatha A. Alduraywish2 · Ayesha Mateen3 · Mohammed S. Alqahtani3 · Rabbani Syed3  \nReceived: 10 August 2024 / Accepted: 17 January 2025  \n© The Author(s) 2025 OPEN  \nAbstract  \nProstate cancer (PCa) remains a significant global health challenge, with approximately 1.6 million new cases and 366,000 deaths annually. Despite high survival rates for localized prostate cancer, recurrence poses a substantial risk due to inherent biological factors and residual disease. Early detection and intervention are essential for enhancing patient outcomesand reducing mortality. However, traditional diagnostics such as PSA tests, digital rectal examinations, and biopsies often lack specificity resulting in overdiagnosis. There is a pressing need for novel biomarkers to enhance precision medicine approaches for PCa. This study employs a machine learning approach to identify DNA methylation and RNA expression biomarkers predictive of PCa recurrence using datasets from The Cancer Genome Atlas (TCGA) . We analyzed 49,133 genes, identifying 684 differentially methylated genes (DMGs) and 691 differentially expressed genes (DEGs) between recurrence and non-recurrence groups. Ten genes (TNNI2, SPIN2, COL5A3, RNF169, CCND1, FGFR1, SLC17A2, FAMM71F2, RREB1, AOX1) were found to have significant correlations between methylation and expression, forming the basis for our predictive model. A support vector machine (SVM) model was developed using these ten genes, achieving an area under the curve (AUC) of 0.773, demonstrating robust predictive capability. Multivariate regression analysis confirmed the SVM score as an independent predictor of recurrence (HR = 0.45; 95% CI 0.28–0.69, P \u003C 0.001). The analysis of recurrence-free survival suggested that patients with low-risk scores experienced significantly better outcomes compared to those with high-risk scores. Functional enrichment analyses of DMGs revealed significant involvement in biological processes such as transcription regulation, signal transduction, and immune response, highlighting the potential mechanistic pathways of these biomarkers. Validation using real-time PCR confirmed differential expression and methylation patterns of the identified genes in prostate cancer (PC3) and non-cancerous cell lines (PNT2). In conclusion, our study hihglights the DNA methylation biomarkers linked to PCa recurrence and introduces a promising SVM model for early prediction, potentially improving treatment outcomes. Further research is needed to explore the biological roles of these genes in PCa aiming to refine therapeutic approaches.  \nKeywords Methylation · Expression · Recurrence · Prostate cancer · Cell lines · Machine learning  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-025-](https://doi.org/10.1007/s12672-025-)[ ](https://doi.org/10.1007/s12672-025-)[01833-8](01833-8.)[.](01833-8.)  \n* Rabbani Syed, [rsyed@ksu.edu.sa](rsyed@ksu.edu.sa); [rsyedrabbani@rediffmail.com](rsyedrabbani@rediffmail.com); Fahad M. Aldakheel, [faldakheel@ksu.edu.sa](faldakheel@ksu.edu.sa); Hadeel Alnajran, [halnajrean@ksu.edu.sa](halnajrean@ksu.edu.sa); Shatha A. Alduraywish, [saduraywesh@ksu.edu.sa](saduraywesh@ksu.edu.sa); Ayesha Mateen, [amateen.c@ksu.edu.sa](amateen.c@ksu.edu.sa); Mohammed  \nS. Alqahtani, [msalqahtani@ksu.edu.sa |](msalqahtani@ksu.edu.sa |1Department of Clinical)[1](msalqahtani@ksu.edu.sa |1Department of Clinical)[Department of Clinical](msalqahtani@ksu.edu.sa |1Department of Clinical) Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, 11433 Riyadh, Saudi Arabia. 2Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. 3Department of Pharmaceutics, College of Pharmacy, King Saud University, P","cbCaikbQemoc40xd","https://ap.wps.com/l/cbCaikbQemoc40xd","pdf",1663594,12,"English","# Abstract\n# Introduction","[{\"question\":\"Why is predicting prostate cancer recurrence important?\",\"answer\":\"Recurrence significantly increases risk due to inherent biological factors and residual disease. Early prediction supports timely intervention and can improve outcomes and survival.\"},{\"question\":\"What biomarkers and data were used to build the recurrence prediction model?\",\"answer\":\"The study uses DNA methylation and RNA expression biomarkers derived from TCGA datasets. It identifies differentially methylated genes and differentially expressed genes between recurrence and non-recurrence groups.\"},{\"question\":\"How was the predictive model constructed and evaluated?\",\"answer\":\"A support vector machine (SVM) model was developed using ten genes showing significant methylation-expression correlations. The model achieved an AUC of 0.773 and multivariate regression supported the SVM score as an independent predictor.\"}]","Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk | PDF",1790181043,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cb3c52ffd1cd26e8f86a2dd591790be.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33432090a32635121af3be93ad60291b.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd376b1b169967f8c8fc7ccc7786b3db.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d86284838cf90d524a2f01413e039191.webp",980,1301]